• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
75,183.36 -135.03
( -0.18%)
Global Indices
Nasdaq
50,311.43 281.08
(0.56%)
Dow Jones
7,466.66 12.69
(0.17%)
Hang Seng
61,747.25 1,942.84
(3.25%)
Nikkei 225
10,466.07 33.73
(0.32%)
Forex
USD-INR
96.52 0.30
(0.32%)
EUR-INR
112.16 0.19
(0.17%)
GBP-INR
129.37 0.68
(0.52%)
JPY-INR
0.61 0.00
(0.22%)

EQUITY - MARKET SCREENER

BSE 500 Quality 50
Industry :  Stock Exchanges
BSE Code
ISIN Demat
Book Value()
1206
N.A
0
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
31.5
0
EPS(TTM)
Face Value()
Div & Yield %
0
100
1.75
 

radhagobind commercial ltd
Ajanta Pharma's Paithan unit concludes USFDA inspection
Apr 22,2026
Ajanta Pharma announced that the USFDA has concluded an inspection at its manufacturing facility at Paithan, in Maharashtra. The Inspection was conducted from 13 April 2026, to 21 April 2026, and closed with the issuance of Form-483 with 5 (five) observations.